PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.970
+0.030 (0.76%)
At close: Dec 5, 2025, 4:00 PM EST
3.968
-0.002 (-0.04%)
After-hours: Dec 5, 2025, 7:09 PM EST
PolyPid Market Cap
PolyPid has a market cap or net worth of $66.04 million as of December 5, 2025. Its market cap has increased by 169.63% in one year.
Market Cap
66.04M
Enterprise Value
51.59M
1-Year Change
169.63%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $66.04M, a decrease of -19.89%. That is a compound annual growth rate of -3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 66.04M | 219.30% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |